Search Count: 12
 |
Crystal Structure Of Human Carbonic Anhydrase Isozyme Ii With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, DMS, MES, V90 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, DMS, MES, V90
 |
Crystal Structure Of Human Carbonic Anhydrase Isozyme Ii With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, V14 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, V14
 |
Crystal Structure Of Human Carbonic Anhydrase Isozyme Ii With 2,3,5,6-Tetrafluoro-4[(2-Hydroxyethyl)Sulfonyl]Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.06 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: EDO, ZN, DMS, BCN, V13, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: EDO, ZN, DMS, BCN, V13, MES
 |
Crystal Structure Of Chimeric Carbonic Anhydrase Ix With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.15 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, DMS, BCN, V90 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, DMS, BCN, V90
 |
Crystal Structure Of Chimeric Carbonic Anhydrase Ix With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.15 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, DMS, V14, BCN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, DMS, V14, BCN
 |
Crystal Structure Of Chimeric Carbonic Anhydrase Xii With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.07 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, DMS, BCN, MES, V90 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, DMS, BCN, MES, V90
 |
Crystal Structure Of Chimeric Carbonic Anhydrase Xii With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, V14, DMS, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, V14, DMS, EDO
 |
Crystal Structure Of Catalytic Domain Of Human Carbonic Anhydrase Isozyme Xii With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2015-01-28 Classification: LYASE/LYASE INHIBITOR Ligands: ZN, V14 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2015-01-28
Ligands: ZN, V14
 |
Structural Characterization Of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2012-05-16 Classification: CHAPERONE Ligands: YI0, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-05-16
Ligands: YI0, MG
 |
Structural Characterization Of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2012-05-16 Classification: CHAPERONE Ligands: YI5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-05-16
Ligands: YI5
 |
Structural Characterization Of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-05-16 Classification: CHAPERONE Ligands: 6QM, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-05-16
Ligands: 6QM, MG
 |
Structural Characterization Of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2012-05-16 Classification: CHAPERONE Ligands: BZ8, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-05-16
Ligands: BZ8, MG